PhIP-Seq

Phage immunoprecipitation sequencing (PhIP-Seq) is method that combines barcoded DNA high-throughput sequencing and proteomics to determine the levels of binding of antibodies to epitopes.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

  • EnglishPhIP-Seq

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Phage immunoprecipitation sequencing (PhIP-Seq) is method that combines barcoded DNA high-throughput sequencing and proteomics to determine the levels of binding of antibodies to epitopes. It has been used to study the autoantibody repertoire of autoimmune diseases like multiple sclerosis, type 2 diabetes and rheumatoid arthritis.[1][2]

References

edit edit source
  1. ^ Larman, H; et al. (2011). "Autoantigen discovery with a synthetic human peptidome". Nature Biotechnology. 29 (6): 535–541. doi:10.1038/nbt.1856. PMC 4169279. PMID 21602805. Wikipedia revision 1150501203, retrieved 2026-11-18
  2. ^ Larman, H; et al. (June 2013). "PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis". Journal of Autoimmunity. 43: 1–9. doi:10.1016/j.jaut.2013.01.013. PMC 3677742. PMID 23497938. Wikipedia revision 1150501203, retrieved 2026-11-18

Text derived from https://en.wikipedia.org/w/index.php?oldid=1150501203 under CC BY-SA 4.0; modifications have been made.